$TMDX Income Statement | Understand Stock

$TMDX

$69.70 -$0.93 (1.32%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of net product revenue
Cost of service revenue
Total revenue
Cost of revenue
Cost of net product revenue
Cost of service revenue
Total cost of revenue
Gross profit
Operating expenses:
Research, development and clinical trials
Acquired in-process research and development expenses
Selling, general and administrative
Total operating expenses
Income (loss) from operations
Other income (expense):
Interest expense
Interest income and other income (expense), net
Total other income (expense), net
Income (loss) before income taxes
(Provision) benefit for income taxes
Net income (loss)
Net income (loss) per share, basic
Net income (loss) per share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted

Comments